[
  {
    "title": "After ousting CEO, Novo Nordisk reclaims crown as largest European company - MarketWatch",
    "link": "https://news.google.com/rss/articles/CBMitwFBVV95cUxNdGpPYjZ1OWlrZlY4ODBDMDVjYW9oWHM1azZ5Q2JpS0JjSmhuejE1bmtYV2l6ZVFEVFJGWDJkMlU5X2Y4N1Vxc2pteHpVSHFPeVdXZTZQakVXMXk3RlZpNWw4XzAycVo4RVBqLXg0YlcyWW0xZEtwX0NMd3JKNDZGTUxFLS1xeVJoSEhhSFM5MHpRbzd4dzFiRHJHYUFna2IzWl9KN3d4N3RFWUswSHRNUHJLV2ZTVHM?oc=5",
    "published": "Fri, 13 Jun 2025 11:14:00 GMT",
    "source": "MarketWatch",
    "summary": "<a href=\"https://news.google.com/rss/articles/CBMitwFBVV95cUxNdGpPYjZ1OWlrZlY4ODBDMDVjYW9oWHM1azZ5Q2JpS0JjSmhuejE1bmtYV2l6ZVFEVFJGWDJkMlU5X2Y4N1Vxc2pteHpVSHFPeVdXZTZQakVXMXk3RlZpNWw4XzAycVo4RVBqLXg0YlcyWW0xZEtwX0NMd3JKNDZGTUxFLS1xeVJoSEhhSFM5MHpRbzd4dzFiRHJHYUFna2IzWl9KN3d4N3RFWUswSHRNUHJLV2ZTVHM?oc=5\" target=\"_blank\">After ousting CEO, Novo Nordisk reclaims crown as largest European company</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">MarketWatch</font>",
    "category": "Strategy & Management"
  },
  {
    "title": "Novo Nordisk fast-tracks oral, SC amycretin into late-stage weight-loss testing - FirstWord Pharma",
    "link": "https://news.google.com/rss/articles/CBMiU0FVX3lxTE9oUnU0Z2paLTF5REFJSE1QNlpScXQ0MFVPcDZzczU5bFMzdDRTdHVDWWhqTUdGN1FwVHVDYnc4dFY5ckdGNVItT0lUdi1ydUZHS0lB?oc=5",
    "published": "Thu, 12 Jun 2025 18:41:27 GMT",
    "source": "FirstWord Pharma",
    "summary": "<a href=\"https://news.google.com/rss/articles/CBMiU0FVX3lxTE9oUnU0Z2paLTF5REFJSE1QNlpScXQ0MFVPcDZzczU5bFMzdDRTdHVDWWhqTUdGN1FwVHVDYnc4dFY5ckdGNVItT0lUdi1ydUZHS0lB?oc=5\" target=\"_blank\">Novo Nordisk fast-tracks oral, SC amycretin into late-stage weight-loss testing</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">FirstWord Pharma</font>",
    "category": "Financials"
  },
  {
    "title": "A $250 mistake seems set to cost Ozempic maker Novo Nordisk billions - Quartz",
    "link": "https://news.google.com/rss/articles/CBMif0FVX3lxTE1PR2hCcTdiVTVrRVVfVGM5WGR5cTl3bWZTR19vYUF6Z1YxWEpOWkE1Wjg2bFVTMXNrT2otLWNSc2U2RDl0ZTlPV1BqUkhUSGJ0MEpnNDBuM2IzZFd5SFc1MnNOZVlsYnBOckQyWkhuM0FUMktwT3IwYnhFWEVtQVU?oc=5",
    "published": "Mon, 16 Jun 2025 14:42:10 GMT",
    "source": "Quartz",
    "summary": "<a href=\"https://news.google.com/rss/articles/CBMif0FVX3lxTE1PR2hCcTdiVTVrRVVfVGM5WGR5cTl3bWZTR19vYUF6Z1YxWEpOWkE1Wjg2bFVTMXNrT2otLWNSc2U2RDl0ZTlPV1BqUkhUSGJ0MEpnNDBuM2IzZFd5SFc1MnNOZVlsYnBOckQyWkhuM0FUMktwT3IwYnhFWEVtQVU?oc=5\" target=\"_blank\">A $250 mistake seems set to cost Ozempic maker Novo Nordisk billions</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Quartz</font>",
    "category": "Investments, M&A & Partnerships"
  },
  {
    "title": "The story of how Novo Nordisk will lose billions because it didn’t pay a couple of hundred dollars - MarketWatch",
    "link": "https://news.google.com/rss/articles/CBMi1wFBVV95cUxOSmYzODExd2VsdHlpLVo1V0o1RnpKTVF6QzVnajRSakI2OF9JUlRxYXpMb2g2U2thazhuVGxZOE13Ynk0NE03aUpleENBZWwtYl9RRlF2ZGZWTzRxdXhXWGpYSXk3QjJ4dTZfWUtESWlRWDhWVDJYQ0hzQmZ5LURtd1pGc3JUWUVCdHZjbVFUcll0UENaOEpUZFBuM2lQcEJ1N0ZfQmpBX2Y4YV9Sek9LbW4yVlcwZHJzeVJseE0yVWc5ZWlaRWlkV0s1c2hDZDZobTRWa2lMZw?oc=5",
    "published": "Mon, 16 Jun 2025 08:24:00 GMT",
    "source": "MarketWatch",
    "summary": "<a href=\"https://news.google.com/rss/articles/CBMi1wFBVV95cUxOSmYzODExd2VsdHlpLVo1V0o1RnpKTVF6QzVnajRSakI2OF9JUlRxYXpMb2g2U2thazhuVGxZOE13Ynk0NE03aUpleENBZWwtYl9RRlF2ZGZWTzRxdXhXWGpYSXk3QjJ4dTZfWUtESWlRWDhWVDJYQ0hzQmZ5LURtd1pGc3JUWUVCdHZjbVFUcll0UENaOEpUZFBuM2lQcEJ1N0ZfQmpBX2Y4YV9Sek9LbW4yVlcwZHJzeVJseE0yVWc5ZWlaRWlkV0s1c2hDZDZobTRWa2lMZw?oc=5\" target=\"_blank\">The story of how Novo Nordisk will lose billions because it didn’t pay a couple of hundred dollars</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">MarketWatch</font>",
    "category": "Commercials"
  },
  {
    "title": "Novo Nordisk Reclaims Top Spot in Europe by Market Value - Insider Monkey",
    "link": "https://news.google.com/rss/articles/CBMiogFBVV95cUxORkFjWUdPYWkxVVN3UHBoV21ZUklwbVRoSGp3Y1FxUHpORm9wS2F3M21iRVptclpQcXB0NjdpaXR0R3VpWHE4RkxTYlN4c1JRQndHb1RyXzBzNmtERXVtSlRNT084akVGOFZScXhkNVBwLXpWWm00emQwVVJFc1M3WWs0WXVtUDNnU0cycVRjNGVudng1NlpVRDJfbE5tYnY2MmfSAaoBQVVfeXFMUE5wN0lUU1ljN3B5eDI2SHBIQXJLb2ZDNlVFN2ZESGRCRm5leklEUkdFM1lKRDdlZk52ZndvRzdiYkMzZk1UUzN5WTNqOXlHdGNmZ3lQTlRnTGxiMG9rWVhYNVVhbGhFcWZWTVNjd2hEd3d4LWh4X29TWlFrNDM0cHloZUVROHdDM0FkZjRuc0ZCdEhWYnNwWWo5Nnl4TFdvdFJuRFpHZk1NcEE?oc=5",
    "published": "Tue, 17 Jun 2025 17:55:52 GMT",
    "source": "Insider Monkey",
    "summary": "<a href=\"https://news.google.com/rss/articles/CBMiogFBVV95cUxORkFjWUdPYWkxVVN3UHBoV21ZUklwbVRoSGp3Y1FxUHpORm9wS2F3M21iRVptclpQcXB0NjdpaXR0R3VpWHE4RkxTYlN4c1JRQndHb1RyXzBzNmtERXVtSlRNT084akVGOFZScXhkNVBwLXpWWm00emQwVVJFc1M3WWs0WXVtUDNnU0cycVRjNGVudng1NlpVRDJfbE5tYnY2MmfSAaoBQVVfeXFMUE5wN0lUU1ljN3B5eDI2SHBIQXJLb2ZDNlVFN2ZESGRCRm5leklEUkdFM1lKRDdlZk52ZndvRzdiYkMzZk1UUzN5WTNqOXlHdGNmZ3lQTlRnTGxiMG9rWVhYNVVhbGhFcWZWTVNjd2hEd3d4LWh4X29TWlFrNDM0cHloZUVROHdDM0FkZjRuc0ZCdEhWYnNwWWo5Nnl4TFdvdFJuRFpHZk1NcEE?oc=5\" target=\"_blank\">Novo Nordisk Reclaims Top Spot in Europe by Market Value</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Insider Monkey</font>",
    "category": "ESG/Sustainability"
  },
  {
    "title": "FDA Launches AI Experiment to Streamline Drug Reviews as Novo Nordisk Faces Rising Competition in Obesity Treatments - geneonline.com",
    "link": "https://news.google.com/rss/articles/CBMi3AFBVV95cUxOSFNNbXdiemV4bml5UGhUQlhRclZTcGM3M0hDb29KYVk4OUlMLVE4ak9ldWlLSGMxTjFUY1p2UkFpQ091UWFxUFp4bzdZWm1KSjNNX1JzV1BubktLRDNlcGFNcXRSVlY5WHJDM2ZiRzlJYUdhamNFdDU5NWdDazlPYWFiUy0xMXdseEJTZ21vUXBDRlpCY0RJZHdzY0pYV3NOeHo2RFdjTzhCbllGeDJsMHFHbTJ1eThEUjRINlJqOUxTb29xcDZsbWdYNTVmcVBySkFCMnV5b2ZnbXNy?oc=5",
    "published": "Wed, 18 Jun 2025 00:07:15 GMT",
    "source": "geneonline.com",
    "summary": "<a href=\"https://news.google.com/rss/articles/CBMi3AFBVV95cUxOSFNNbXdiemV4bml5UGhUQlhRclZTcGM3M0hDb29KYVk4OUlMLVE4ak9ldWlLSGMxTjFUY1p2UkFpQ091UWFxUFp4bzdZWm1KSjNNX1JzV1BubktLRDNlcGFNcXRSVlY5WHJDM2ZiRzlJYUdhamNFdDU5NWdDazlPYWFiUy0xMXdseEJTZ21vUXBDRlpCY0RJZHdzY0pYV3NOeHo2RFdjTzhCbllGeDJsMHFHbTJ1eThEUjRINlJqOUxTb29xcDZsbWdYNTVmcVBySkFCMnV5b2ZnbXNy?oc=5\" target=\"_blank\">FDA Launches AI Experiment to Streamline Drug Reviews as Novo Nordisk Faces Rising Competition in Obesity Treatments</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">geneonline.com</font>"
  },
  {
    "title": "Novo Nordisk Reclaims Top Spot in Europe by Market Value - Yahoo Finance",
    "link": "https://news.google.com/rss/articles/CBMiggFBVV95cUxNVVJiNW9fSU5MU0Vib3FleWNHcjctZjlQX2lPRTZNcGFqY3JPdjYzWHFCdkh3NFNFRm1nMUoybXlnOXpEWDdLZnd1c0I3SFVIcmNKcV80dFBxSF9EczhxMG44aHcwbGNTTHZSekc3bmdBc1p4TDBvMWxZcF82b1pzczZ3?oc=5",
    "published": "Tue, 17 Jun 2025 17:48:08 GMT",
    "source": "Yahoo Finance",
    "summary": "<a href=\"https://news.google.com/rss/articles/CBMiggFBVV95cUxNVVJiNW9fSU5MU0Vib3FleWNHcjctZjlQX2lPRTZNcGFqY3JPdjYzWHFCdkh3NFNFRm1nMUoybXlnOXpEWDdLZnd1c0I3SFVIcmNKcV80dFBxSF9EczhxMG44aHcwbGNTTHZSekc3bmdBc1p4TDBvMWxZcF82b1pzczZ3?oc=5\" target=\"_blank\">Novo Nordisk Reclaims Top Spot in Europe by Market Value</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Yahoo Finance</font>"
  },
  {
    "title": "Novo Nordisk focused on biotech deals for cardiometabolic indications - Seeking Alpha",
    "link": "https://news.google.com/rss/articles/CBMiogFBVV95cUxOY0hiajBkRktBQkRSMFJhV3A0cnhsaU9LZXdOSS1QQU9Gb2dxbUZwWGdTSjFMZGxvNFAtTF9kenhoNXRmaTVDUlVxeGg0ZmtXS0paT01sejJXbENDUTdaLUZDOUIyeFVjRmZtOEtjc1h3UHdENFVJVWhhY2RPc3ZWNkdMcVhLRW93Ty1INGFaXzZKV1dyNlRfRl9yQzVSN1VLdXc?oc=5",
    "published": "Tue, 17 Jun 2025 21:37:00 GMT",
    "source": "Seeking Alpha",
    "summary": "<a href=\"https://news.google.com/rss/articles/CBMiogFBVV95cUxOY0hiajBkRktBQkRSMFJhV3A0cnhsaU9LZXdOSS1QQU9Gb2dxbUZwWGdTSjFMZGxvNFAtTF9kenhoNXRmaTVDUlVxeGg0ZmtXS0paT01sejJXbENDUTdaLUZDOUIyeFVjRmZtOEtjc1h3UHdENFVJVWhhY2RPc3ZWNkdMcVhLRW93Ty1INGFaXzZKV1dyNlRfRl9yQzVSN1VLdXc?oc=5\" target=\"_blank\">Novo Nordisk focused on biotech deals for cardiometabolic indications</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Seeking Alpha</font>"
  },
  {
    "title": "Novo Nordisk finds Deep Apple ripe for obesity R&D, inking $812M deal to go beyond incretins - Fierce Biotech",
    "link": "https://news.google.com/rss/articles/CBMivAFBVV95cUxQTlB5OXlsbzJTWWpoVHJHN2MyS3FRMVZBODBieXJfVjlZRE5LTmRxTnQ1OW9jajg1eVNJLUNzdGRiX0V3eUdaVnBLN1N4NlItTTMwUlNsemVka3ZucmR1MFJMbFRaRWtPdDhsTVdMejdJRmlEd1BJWm9Td3NnZXFfVU5kRnBBRTJSVlp5V1dpSS1HSXl3STVvWXBlSEdZTWtMSGtINzliTDFYQ0prR2Z6cF9LdVFsVFdFSE9JVg?oc=5",
    "published": "Wed, 11 Jun 2025 11:00:00 GMT",
    "source": "Fierce Biotech",
    "summary": "<a href=\"https://news.google.com/rss/articles/CBMivAFBVV95cUxQTlB5OXlsbzJTWWpoVHJHN2MyS3FRMVZBODBieXJfVjlZRE5LTmRxTnQ1OW9jajg1eVNJLUNzdGRiX0V3eUdaVnBLN1N4NlItTTMwUlNsemVka3ZucmR1MFJMbFRaRWtPdDhsTVdMejdJRmlEd1BJWm9Td3NnZXFfVU5kRnBBRTJSVlp5V1dpSS1HSXl3STVvWXBlSEdZTWtMSGtINzliTDFYQ0prR2Z6cF9LdVFsVFdFSE9JVg?oc=5\" target=\"_blank\">Novo Nordisk finds Deep Apple ripe for obesity R&amp;D, inking $812M deal to go beyond incretins</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Fierce Biotech</font>"
  },
  {
    "title": "Novo Nordisk starts new CagriSema weightloss drug trial - Reuters",
    "link": "https://news.google.com/rss/articles/CBMixgFBVV95cUxPNDFsUXJJV1BFWjIzc2tWNmJaUVJXelNDel9lY2ZHMm10SFdjZk10eVVOcHpCMHc0SFNya2l2OE9rRW51bTVfMHlTR2czRmFSQm1qdm9RRkdvc1RSQm1pWExoN3QzODZYOXFISTlVRkUtaTJtckt1Mm1qd0poeDk2TjF6QmtrdTMtUU8wWnRoamI5OWxqU0g2WC1iR0NpVnFxbHJPaXM1WXg2elZNTzRKdkJGOXNuRnJHc084cXFheVYzcjNNbVE?oc=5",
    "published": "Tue, 10 Jun 2025 17:01:43 GMT",
    "source": "Reuters",
    "summary": "<a href=\"https://news.google.com/rss/articles/CBMixgFBVV95cUxPNDFsUXJJV1BFWjIzc2tWNmJaUVJXelNDel9lY2ZHMm10SFdjZk10eVVOcHpCMHc0SFNya2l2OE9rRW51bTVfMHlTR2czRmFSQm1qdm9RRkdvc1RSQm1pWExoN3QzODZYOXFISTlVRkUtaTJtckt1Mm1qd0poeDk2TjF6QmtrdTMtUU8wWnRoamI5OWxqU0g2WC1iR0NpVnFxbHJPaXM1WXg2elZNTzRKdkJGOXNuRnJHc084cXFheVYzcjNNbVE?oc=5\" target=\"_blank\">Novo Nordisk starts new CagriSema weightloss drug trial</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Reuters</font>"
  }
]